Evidence map›Paper›PMID 28778956›Full record

ArticleThe EMBO journal2017

Histone H4K20 tri-methylation at late-firing origins ensures timely heterochromatin replication.

Julien Brustel, Nina Kirstein, Fanny Izard, Charlotte Grimaud, Paulina Prorok, Christelle Cayrou, Gunnar Schotta, Alhassan F Abdelsamie, Jérôme Déjardin, Marcel Méchali and 5 more

Abstract read
In one paragraph

Article in The EMBO journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Targeting KMT5C Suppresses Lung Cancer Progression and Enhances the Efficacy of Immunotherapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Genes & development · 2024
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. STAG2 Regulates Homologous Recombination Repair and Sensitivity to ATM Inhibition.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. ORChestra coordinates the replication and repair music.BioEssays : news and reviews in molecular, cellular and developmental biology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Julien BrustelInstitut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Institut Régional du Cancer (ICM), Montpellier, France.
Nina KirsteinResearch Unit Gene Vectors, Helmholtz Zentrum München, Munich, Germany.
Fanny IzardInstitut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Institut Régional du Cancer (ICM), Montpellier, France.
Charlotte GrimaudInstitut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Institut Régional du Cancer (ICM), Montpellier, France.
Paulina ProrokInstitute of Human Genetics (IGH), CNRS, Montpellier, France.
Christelle CayrouInstitute of Human Genetics (IGH), CNRS, Montpellier, France.
Gunnar SchottaBiomedical Center Munich, Planegg-Martinsried, Germany.ORCID 0000-0003-4940-6135
Alhassan F AbdelsamieResearch Unit Gene Vectors, Helmholtz Zentrum München, Munich, Germany.
Jérôme DéjardinInstitute of Human Genetics (IGH), CNRS, Montpellier, France.
Marcel MéchaliInstitute of Human Genetics (IGH), CNRS, Montpellier, France.
Giuseppe BaldacciInstitut Jacques Monod, UMR7592, CNRS and University Paris-Diderot, Paris, France.
Claude SardetInstitut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Institut Régional du Cancer (ICM), Montpellier, France.
Jean-Charles CadoretInstitut Jacques Monod, UMR7592, CNRS and University Paris-Diderot, Paris, France jean-charles.cadoret@ijm.fr schepers@helmholtz-muenchen.de eric.julien@inserm.fr.ORCID 0000-0002-3827-5208
Aloys SchepersResearch Unit Gene Vectors, Helmholtz Zentrum München, Munich, Germany jean-charles.cadoret@ijm.fr schepers@helmholtz-muenchen.de eric.julien@inserm.fr.ORCID 0000-0002-5442-5608
Eric JulienInstitut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Institut Régional du Cancer (ICM), Montpellier, France jean-charles.cadoret@ijm.fr schepers@helmholtz-muenchen.de eric.julien@inserm.fr.ORCID 0000-0003-2976-666X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Among other targets, the protein lysine methyltransferase PR-Set7 induces histone H4 lysine 20 monomethylation (H4K20me1), which is the substrate for further methylation by the Suv4-20h methyltransferase. Although these enzymes have been implicated in control of replication origins, the specific contribution of H4K20 methylation to DNA replication remains unclear. Here, we show that H4K20 mutation in mammalian cells, unlike in

Indexed as

DNA ReplicationProtein Processing, Post-TranslationalHeterochromatinHistone-Lysine N-MethyltransferaseHistonesHumansLysineMethylationHeterochromatinHistone-Lysine N-MethyltransferaseHistonesKMT5C protein, humanLysineDNA replication originsheterochromatinhistone H4K20 methylation

Identifiers

PMID28778956
PMCPMC5599798

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.